According to the World Health Organization (WHO), the global elderly population is expected to reach around 2 billion by 2050, which was around 524 million in 2010. The tissue sealants market has witnessed a number of acquisitions in the past few years. Strategic acquisitions help companies to expand their market share, which in turn would act positively to record high market revenue. In January 2014, Integra Lifesciences Corporation completed the acquisition of Covidien, plc.’s Confluent Surgical product line that includes surgical sealant (DuraSeal, VascuSeal and SprayShield) and adhesion barrier products.
The world is witnessing a continuous increase in number of surgical procedures primarily due to factors such as continued increase in number of trauma conditions as a result of road accident and natural disaster, escalating cases of cardiovascular diseases leading to increased number of cardiac surgeries and rise in number of sports injuries. The increasing volume of surgical procedures in turn drives the market growth by boosting the demand for tissue sealants. Furthermore, an increasing awareness among surgeons with respect to benefits associated with tissue sealants is driving the market growth. A number of surgical procedures carried out globally use tissue sealants in a varied range of indications. Elderly people are more susceptible to undergo various surgical procedures. Hence, rising aging population is likely to drive the tissue sealants market growth.
Download PDF brochure for this Report:
Tissue sealants are viscous pliable materials that have adhesive, cohesive, and hemostatic properties. They act as a protective barrier to prevent leakage of fluid from the surgical site. The global market for tissue sealants has been broadly classified into natural tissue sealants and synthetic tissue sealants. Natural tissue sealants consist of biological components such as cryoprecipitate and fibrin that stimulate the body’s natural clotting process. The market for natural tissue sealants is further categorized as fibrin sealants and other natural tissue sealants. Fibrin tissue sealants are viscous materials that allow quick healing by forming fibrin clot. Other natural tissue sealants are albumin and collagen-based natural tissue sealants.
Synthetic tissue sealants are composed of a variety of artificial materials such as synthetic peptides, polyethylene glycol, and protein polymers. They serve as a primary barrier to stop bleeding. Synthetic tissue sealant products are chemical compounds formed by linking different types of monomers. The market for synthetic tissue sealants is further segmented as cynoacrylate based tissue sealants and others (polyethylene glycol and others).
On the basis of geography, the global tissue sealants market can be segmented into four major regions, namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). North America represented the largest regional market for tissue sealants in 2013. In addition to well established healthcare infrastructure of the region, rapidly increasing elderly population is also one of the major reasons responsible for North America holding the leading position in the area of tissue sealants market.
According to the U.S. Census Bureau, around 89 million people will be aged over 65 years in the U.S. by 2050. In Asia-Pacific region, Japan, China, India and Australia represents the most potential markets. As per the statistics released by the WHO, It is projected that by 2060, 40% Japanese will be aged over 65 years. This rapid increase in the geriatric population is likely to drive the growth of the tissue sealants market during the forecast period from 2014 to 2020.
Baxter Healthcare, Johnson & Johnson Services, Inc., C.R. Bard, Inc., Integra LifeSciences Corporation, Cohesion Technologies, Inc., Hemacure, and Genzyme Corporation are some major players operating in the tissue sealants market.
Browse Full Research Report on Tissue Sealants Market:
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR Syndicated Research report covers a different sector - such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453
Browse market research blog: